Q4 2023 · 13F-HR
Velan Capital Investment Management LPholdings as filed
Filed 2024-02-14 · accession 0001848809-24-000005
$171.3M
Reported value
20
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 016259202 | — | ALIMERA SCIENCES INC | $58.8M | 34.3% | 13,608,533 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $30.1M | 17.6% | 150,000 | PUT | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $11.9M | 6.93% | 6,986,744 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $9.7M | 5.64% | 2,136,100 | Common | SOLE |
| 471871103 | — | JASPER THERAPEUTICS INC | $8.6M | 4.99% | 11,219,036 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $8.4M | 4.88% | 319,080 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $7.7M | 4.50% | 345,666 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $5.6M | 3.28% | 189,500 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $5.6M | 3.28% | 500,000 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $4.9M | 2.86% | 3,796,861 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.7M | 2.71% | 75,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $3.7M | 2.14% | 18,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $3.0M | 1.75% | 50,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $2.5M | 1.48% | 904,029 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $1.8M | 1.08% | 1,761,595 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.6M | 0.96% | 778,500 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $1.2M | 0.68% | 27,500 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $885,288 | 0.52% | 172,235 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $513,050 | 0.30% | 77,500 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $267,050 | 0.16% | 497,299 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.